According to a new study from the Centers for Disease Control and Prevention, the U.S. burden of Alzheimer’s disease and related dementias (ADRD) in people 65 and older will double by 2060.
Dr. Christopher Christodoulou, Clinical and Research Neuropsychologist at Stony Brook Center of Excellence for Alzheimer's Disease is available to discuss this topic and is available by phone, Skype or live via the VideoLink Studio located on the Stony Brook University campus.
His comments on the study:
- The rapid growth in the US population over 65 years of age is expected to strongly contribute to a substantial rise of the prevalence of Alzheimer's disease and related dementias, from about 5.5 million now to almost 14 million by 2060.
- There are significant differences in rates of dementia between groups of Americans based on race and ethnicity, with African Americans and Hispanics at higher risk.
- The results highlight the need to develop culturally sensitive public health plans to encourage healthy lifestyle changes (e.g., regular exercise, Mediterranean diet) across all racial and ethnic groups.
Disorders of the brain in particular exact a terrible toll on humankind at all ages of life. The Stony Brook Neurosciences Institute has been continuously engaged in combating Alzheimer’s disease for over three decades — through basic, translational and clinical research, diagnosis, treatment and education.
To provide care for patients and support for families, Stony Brook Center of Excellence for Alzheimer’s Disease aims to enhance the quality of life of people living with Alzheimer’s disease, dementia or dementia disorders and it offers everything from assessment and diagnostic services and individualized care plans to referrals and outreach.
To schedule an interview with Dr. Christopher Christodoulou, contact Kali Chan, Director of Medicine Media Relations at 631-487-4092 or [email protected].
Find more experts at Stony Brook University here.
RSS